Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Modular MedicalMODD +2.70%21 3-Year EBITDA Growth Rate is 30.70% as of Mar. 2026. GuruFocus rates MODD with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 692 Medical Devices & Instruments companies, Modular Medical ranks better than 77.75% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 30.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 26.20% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -28.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Modular Medical was 40.60% per year. The lowest was -146.60% per year. And the median was -8.60% per year.
Modular Medical (NAS:MODD) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Modular Medical 3-Year EBITDA Growth Rate Related Terms
MODD vs TANAF, CTSO, NMTC: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, Modular Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modular Medical 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Modular Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Modular Medical's 3-Year EBITDA Growth Rate falls into.
Modular Medical 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 30.70% mean?
Modular Medical (MODD) has a 3-Year EBITDA Growth Rate of 30.70% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Modular Medical and its competitors. According to the industry distribution chart, Modular Medical ranks #154 out of 692 companies in the Medical Devices & Instruments industry, placing it in the top 22.3%.
Is Modular Medical's 3-Year EBITDA Growth Rate too high?
Modular Medical's current 3-Year EBITDA Growth Rate is 30.70%. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 7.65. Modular Medical's value of 30.70% is 301.3% above this industry median. Based on the distribution chart, Modular Medical ranks #154 out of 692 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Modular Medical has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Modular Medical's 3-Year EBITDA Growth Rate compare to TANAF and CTSO?
According to the Medical Devices & Instruments industry distribution chart, Modular Medical ranks #154 out of 692 companies for 3-Year EBITDA Growth Rate. This places Modular Medical in the top 22% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 7.65. Modular Medical's value of 30.70% is 301.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.65, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modular Medical's current 3-Year EBITDA Growth Rate of 30.70% is 301.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Modular Medical and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modular Medical's current 3-Year EBITDA Growth Rate is 30.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modular Medical stock overvalued right now?
Modular Medical (MODD) has a current 3-Year EBITDA Growth Rate of 30.70%. The current 3-Year EBITDA Growth Rate is 30.70% and 301.3% above the Medical Devices & Instruments industry median of 7.65. Modular Medical's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Modular Medical (MODD), the current 3-Year EBITDA Growth Rate is 30.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
21GF Score
Get the complete analysis for MODD
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MODD has been successfully added to your 
